HDT Bio Receives ARPA-H GIVE Award to Lead Development of Automated, Point-of-Care Manufacturing for Personalized RNA Medicines
Award of up to $39.5 million funds a closed, end-to-end RNA manufacturing and quality-control platform; program includes a personalized cancer immunotherapy demonstration with Houston Methodist Research Institute and marks HDT Bio's expansion into personalized cancer medicine SEATTLE,...